Edward Nash Sees Otonomy as a Pure Speculative Pharma Play
Though NDA Gets Stalled, Analyst Says Catalyst “Still on Track”
SunTrust analyst Edward Nash has left the sidelines, downgrading his rating from a Hold to a Sell on Cempra Inc (NASDAQ:CEMP). Nash notes he expects the …